1. Suh M, Kim HH, Sohn MH, Kim KE, Kim C, Shin DC. Prevalence of allergic diseases among Korean school-age children: a nationwide cross-sectional questionnaire study. J Korean Med Sci. 2011. 26:332–338.
2. Hong SJ, Ahn KM, Lee SY, Kim KE. The prevalences of asthma and allergic diseases in Korean children. Pediatr Allergy Respir Dis. 2008. 18:15–25.
3. Holm EA, Wulf HC, Stegmann H, Jemec GB. Life quality assessment among patients with atopic eczema. Br J Dermatol. 2006. 154:719–725.
4. Cho HN, Hong S, Lee SH, Yum HY. Nutritional status according to sensitized food allergens in children with atopic dermatitis. Allergy Asthma Immunol Res. 2011. 3:53–57.
5. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung DY, Lipozencic J, Luger TA, Muraro A, Novak N, Platts-Mills TA, Rosenwasser L, Scheynius A, Simons FE, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T. European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006. 118:152–169.
6. Long CC, Funnell CM, Collard R, Finlay AY. What do members of the National Eczema Society really want? Clin Exp Dermatol. 1993. 18:516–522.
7. Park JS, Kim BJ, Park Y, Lee SY, Kim WK, Kim JE, Yum HY, Nahm DH, Kim HH, Hong SJ, Oh JW, Lee AY, Kim KH. KAAACI Work Group on Severe/Recalcitrant Atopic Dermatitis. KAAACI work group report on the treatment of severe/recalcitrant atopic dermatitis. Korean J Asthma Allergy Clin Immunol. 2010. 30:255–270.
8. Korean Academy of Pediatric Allergy and Respiratory Disease. Guideline of atopic dermatitis in Korean children. 2008. 1st ed. Seoul: Kwangmun Press.
9. Kimata H. High dose gammaglobulin treatment for atopic dermatitis. Arch Dis Child. 1994. 70:335–336.
10. Gelfand EW, Landwehr LP, Esterl B, Mazer B. Intravenous immune globulin: an alternative therapy in steroid-dependent allergic diseases. Clin Exp Immunol. 1996. 104:Suppl 1. 61–66.
11. Hanna K, Poulin-Costello M, Preston M, Maresky N. Intravenous immune globulin use in Canada. Can J Clin Pharmacol. 2003. 10:11–16.
12. Leung DY. Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol. 1997. 107:Suppl 1. 25–30.
13. Jolles S, Hughes J, Rustin M. Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis. J Am Acad Dermatol. 1999. 40:121–123.
14. Jee SJ, Kim JH, Baek HS, Lee HB, Oh JW. Long-term efficacy of intravenous immunoglobulin therapy for moderate to severe childhood atopic dermatitis. Allergy Asthma Immunol Res. 2011. 3:89–95.